Ubs Group Ag Haleon PLC Transaction History

Ubs Group Ag

$528 Billion
Q1 2025

A detailed history of Ubs Group Ag transactions in Haleon PLC stock. As of the latest transaction made, Ubs Group Ag holds 14,360,899 shares of HLN stock, worth $148 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

14,360,899

Previous 6,728,886 113.42%

Holding current value

$148 Million

Previous $64.3 Million 129.72%

% of portfolio

0.03%

Previous 0.01%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$9.02 - $10.67 $68.8 Million - $81.4 Million	7,632,013 Added 113.42%	14,360,899 $148 Million
Q4 2024 Feb 14, 2025	BUY	$9.23 - $10.71 $49.6 Million - $57.6 Million	5,376,276 Added 397.47%	6,728,886 $64.3 Million
Q3 2024 Nov 14, 2024	SELL	$8.32 - $10.7 $1.82 Million - $2.34 Million	-218,851 Reduced 13.93%	1,352,610 $14.3 Million
Q2 2024 Aug 13, 2024	SELL	$8.01 - $8.64 $2.21 Million - $2.38 Million	-275,993 Reduced 14.94%	1,571,461 $13 Million
Q1 2024 May 13, 2024	BUY	$8.02 - $8.67 $2.48 Million - $2.68 Million	309,434 Added 20.12%	1,847,454 $15.7 Million
Q4 2023 Feb 09, 2024	SELL	$7.78 - $8.62 $269,180 - $298,243	-34,599 Reduced 2.2%	1,538,020 $12.7 Million
Q3 2023 Nov 09, 2023	SELL	$7.85 - $8.94 $447,426 - $509,553	-56,997 Reduced 3.5%	1,572,619 $13.1 Million
Q2 2023 Aug 11, 2023	SELL	$8.04 - $9.0 $1.16 Million - $1.3 Million	-144,407 Reduced 8.14%	1,629,616 $13.7 Million
Q1 2023 May 12, 2023	BUY	$7.57 - $8.37 $397,841 - $439,885	52,555 Added 3.05%	1,774,023 $14.4 Million
Q4 2022 Feb 08, 2023	BUY	$5.96 - $8.06 $57,436 - $77,674	9,637 Added 0.56%	1,721,468 $13.8 Million
Q3 2022 Nov 10, 2022	BUY	$5.63 - $7.5 $9.64 Million - $12.8 Million	1,711,831 New	1,711,831 $10.4 Million

Others Institutions Holding HLN

# of Institutions

661

Shares Held

451M

Call Options Held

269K

Put Options Held

40.6K

View Full List

About Haleon plc

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $47.5B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

More about HLN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account